In complicated UTI or pyelonephritis, cefepime-enmetazobactam increased success vs piperacillin-tazobactam at 14 ddoi:10.7326/J22-0114... DG Maki - 《Annals of Internal Medicine》 被引量: 0发表: 2023年 LB-4. Cefepime-Enmetazobactam Demonstrates Superiority to Piperacillin-Tazobactam in a Subgroup...
diabetes, a larger number of prior deliveries, and lower socioeconomic status are at higher risk.[115]Without treatment, up to 35% progress to a symptomatic UTI and/or pyelonephritis during the pregnancy.[116]Most studies suggest untreated
ABU (Asymptomatic Bacteriuria), Complicated UTI. Pyelonephritis, AKI, CLED, FBS, PPBS, HbA1c.D. MarkendeyuluG. Murthy
Describing the results in theJournal of the American Medical Association(JAMA), researchers in the ALLIUM Phase 3 clinical trial showed that a combination of the drugs cefepime and enmetazobactam was more effective in treating both complicated urinary tract infections and acute pyelonephritis (AP), a...
pyelonephritis with normal urinary tract anatomy, obstructive uropathy, renal impairment caused by intrinsic renal disease, urinary retention or urinary tract modifications; and at least one of the following signs or symptoms: dysuria, urinary frequency, or urinary urgency, UTI-related altered mental sta...
UTI and diagnosed with cUTI with or without pyelonephritis, or acute uncomplicated pyelonephritis, including immunosuppressed patients with renal transplant [28]. Patients with acute uncomplicated pyelonephritis were limited to 30% in this study to assess more complicated MDR infections in older patients ...
Conclusions and Relevance Among patients with complicated UTI, including acute pyelonephritis and growth of a baseline pathogen, meropenem-vaborbactam vs piperacillin-tazobactam resulted in a composite outcome of complete resolution or improvement of symptoms along with microbial eradication that met the non...
Oral vs Intravenous Ciprofloxacin in the Initial Empirical Management of Severe Pyelonephritis or Complicated Urinary Tract InfectionsThere are few data on the efficacy of oral antibiotics in the initial empirical management of severe forms of urinary tract infection (UTI).In a multicenter, prospective,...
1974. Ceftriaxone-Sulbactam-EDTA vs. Meropenem in PLEA (a Phase 3, Randomized, Double-Blind Trial): Outcomes by Baseline MIC in Adults With Complicated Urinary Tract Infections or Acute Pyelonephritis BACKGROUND. Ceftriaxone–sulbactam–disodium EDTA (CSE) is being developed for Gram-negative infectio...
The findings show a higher rate of quinolone resistance than those found in other studies conducted in Europe and the United States, which include community-acquired uncomplicated lower UTI, complicated lower UTI, and pyelonephritis, ranging between 23 and 31% [8,20,21,22,23]. The high ...